FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma

Affiliations

• 1 Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
• 2 Department of Gastrointestinal Surgery, the Affiliated Changzhou, No. 2 People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China.
• 3 Institute of Organoid Technology, BioGenous Biotechnology, Inc., Suzhou, China.
• 4 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
• 5 Joint Center for Translational Medicine, Fengxian District Central Hospital, Fengxian District, Shanghai, China.
• 6 Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
• 7 School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
• 8 Chongqing Key Laboratory of Precision Optics, Chongqing Institute of East China Normal University, Chongqing, China.
• 9 Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.